These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23114811)

  • 21. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).
    Hyttel J
    Int Clin Psychopharmacol; 1994 Mar; 9 Suppl 1():19-26. PubMed ID: 8021435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serotonin now: Part 1. Neurobiology and developmental genetics].
    Kriegebaum C; Gutknecht L; Schmitt A; Lesch KP; Reif A
    Fortschr Neurol Psychiatr; 2010 Jun; 78(6):319-31. PubMed ID: 20340067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonergic mechanisms and the new antidepressants.
    Stahl SM
    Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of norepinephrine in depression.
    Delgado PL; Moreno FA
    J Clin Psychiatry; 2000; 61 Suppl 1():5-12. PubMed ID: 10703757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic properties of serotonergic agents and antidepressant drugs.
    Fuller RW
    J Clin Psychiatry; 1987 Mar; 48 Suppl():5-11. PubMed ID: 3493240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
    Ichikawa J; Ishii H; Bonaccorso S; Fowler WL; O'Laughlin IA; Meltzer HY
    J Neurochem; 2001 Mar; 76(5):1521-31. PubMed ID: 11238736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The pharmacological basis of the serotonin system: Application to antidepressant response].
    David DJ; Gardier AM
    Encephale; 2016 Jun; 42(3):255-63. PubMed ID: 27112704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment.
    de Montigny C; Blier P; Chaput Y
    Neuropharmacology; 1984 Dec; 23(12B):1511-20. PubMed ID: 6396527
    [No Abstract]   [Full Text] [Related]  

  • 29. Two actions are better than one: avoiding self-inhibition of serotonergic neurones enhances the effects of serotonin uptake inhibitors.
    Romero L; Bel N; Casanovas JM; Artigas F
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():1-8. PubMed ID: 8923121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antidepressants, stressors and the serotonin 1A receptor].
    Kirilly E; Gonda X; Bagdy G
    Neuropsychopharmacol Hung; 2015 Jun; 17(2):81-9. PubMed ID: 26192901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.
    Blier P; Szabo ST
    J Clin Psychiatry; 2005; 66 Suppl 8():30-40. PubMed ID: 16336034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents.
    Dubovsky SL
    J Clin Psychiatry; 1994 Feb; 55 Suppl():34-44. PubMed ID: 8077173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neuropharmacology of serotonin and noradrenaline in depression.
    Nutt DJ
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function.
    Dale E; Pehrson AL; Jeyarajah T; Li Y; Leiser SC; Smagin G; Olsen CK; Sanchez C
    CNS Spectr; 2016 Apr; 21(2):143-61. PubMed ID: 26346726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A
    Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.
    Horacek J; Bubenikova-Valesova V; Kopecek M; Palenicek T; Dockery C; Mohr P; Höschl C
    CNS Drugs; 2006; 20(5):389-409. PubMed ID: 16696579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of rapid-onset antidepressant treatment strategies.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.
    Blier P; de Montigny C
    Biol Psychiatry; 1998 Sep; 44(5):313-23. PubMed ID: 9755353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study.
    Gobbi G; Murphy DL; Lesch K; Blier P
    J Pharmacol Exp Ther; 2001 Mar; 296(3):987-95. PubMed ID: 11181933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.